Endovascular therapy of symptomatic intracranial stenosis in patients with impaired regional cerebral blood flow or failure of medical therapy

American Journal of Neuroradiology

Volumn 29, Issue 2, 2008, Pages 273-280

  Puetz, Volker ^a   Gahn, G ^a   Becker, U ^a   Mucha, D ^a   Mueller, A ^a   Weir, N U ^b   Wiedemann, B ^a   Von Kummer, R ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ALTEPLASE; ANTICOAGULANT AGENT; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BRAIN BLOOD FLOW; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DRUG TREATMENT FAILURE; ENDOVASCULAR THERAPY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTERVENTIONAL RADIOLOGY; KAPLAN MEIER METHOD; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; RECURRENT DISEASE; RETROSPECTIVE STUDY; STENT; SURVIVAL; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; BLOOD VESSEL PROSTHESIS; BRAIN ISCHEMIA; CAROTID STENOSIS; COMORBIDITY; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT FAILURE;

EID: 39649107167     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A0829     Document Type: Article

References (33)

1. Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995;26:14-20
2. Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974-80
3. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 1985;313:1191-200
4. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-16
5. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-63
6. Berkefeld J, Hamann GF, du Mesnil R, et al. [Endovascular treatment for in tracranial stenoses. A common statement by neurologists and neuroradiologists]. Nervenarzt 2006;77:1444-55
7. Ecker RD, Levy EI, Sauvageau E, et al. Current concepts in the management of intracranial atherosclerotic disease. Neurosurgery 2006;59(5 Suppl 3):S210-18; discussion S3-13
8. Higashida RT, Meyers PM. Intracranial angioplasty and stenting for cerebral atherosclerosis: new treatments for stroke are needed! Neuroradiology 2006;48:367-72
9. Klopfenstein JD, Ponce FA, Kim LJ, et al. Middle cerebral artery stenosis: endovascular and surgical options. Skull Base 2005;15:175-89
10. Barrett KM, Ackerman RH, Gahn G, et al. Basilar and middle cerebral artery reserve: a comparative study using transcranial Doppler and breath-holding techniques. Stroke 2001;32:2793-96
11. Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty of intracranial stenosis: long-term clinical outcome. In Proceedings of the American Society of Neuroradiology (abstract); 2005.
12. Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016-20
13. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415-25
14. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490-97
15. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998;55:1475-82
16. Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006;66:1187-91
17. Mori T, Fukuoka M, Kazita K, et al. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525-33
18. Cruz-Flores S, Diamond AL. Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev 2006;3:CD004133
19. Jiang WJ, Xu XT, Du B, et al. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 2007;68:420-26
20. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-24
21. du Mesnil de Rochemont R, Sitzer M, Zanella FE, et al. [Stenting in acute stroke]. Radiologe 2005;45:461-65
22. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388-92
23. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881-87
24. Boulos AS, Agner C, Deshaies EM. Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res 2005;27 Suppl 1:S95-102
25. Gupta R, Schumacher HC, Mangla S, et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003;61:1729-35
26. Qureshi AI, Saad M, Zaidat OO, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 2002;33:1916-19
27. Chow MM, Masaryk TJ, Woo HH, et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol 2005;26:869-74
28. Kim JK, Ahn JY, Lee BH, et al. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 2004;75:847-51
29. Jiang WJ, Xu XT, Jin M, et al. Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol 2007;28:830-34
30. Maisel WH. Unanswered questions - drug-eluting stents and the risk of late thrombosis. N Engl J Med 2007;356:981-84
31. Girot M, Leclerc X, Gauvrit JY, et al. Cerebral magnetic resonance imaging within 6 hours of stroke onset: inter- and intra-observer reproducibility. Cerebrovasc Dis 2003;16:122-27
32. Samuels OB, Joseph GJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643-46
33. Sauvageau E, Ecker RD, Levy EI, et al. Recent advances in endoluminal revascularization for intracranial atherosclerotic disease. Neurol Res 2005;27 Suppl 1:S89-94